Risk Prediction for Contrast Induced Nephropathy in patients with renal impairment
Not Applicable
- Conditions
- Health Condition 1: - Health Condition 2: I219- Acute myocardial infarction, unspecified
- Registration Number
- CTRI/2019/06/019604
- Lead Sponsor
- GE Healthcare Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All consecutive patients aged 18 to 80 years, who undergo PCI in the study sites can be enrolled into the study, if their GFR is 15- 60ml/min/1.73m2, in whom Iodixanol is the contrastmedia of choice. The screening tests required for the study must be performed in all patients.
Exclusion Criteria
Evidence of acute renal failure before PCI, patients on regular dialysis, cardiogenic shock, patients who were exposed to contrast media within 14 days, patients exposed to nephrotoxic medication within 48hours of the procedure, patients requiring intra-aortic balloon pump (IABP) support and patients who developed PCI related complications will be ex¬cluded.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method o outcome for this studyTimepoint: No outcome for this study
- Secondary Outcome Measures
Name Time Method o outcome for this studyTimepoint: No outcome for this study